Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0001758363-26-000002

Chief Executive Officer sold 15,000 shares at an average $30.68 ($460,134)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Turtle Cameron · Chief Executive Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-02 Sale : show line 1 in the form 10b5-1 −12,709 $30.47 $387,243 674,198 D
2026-01-02 Sale : show line 2 in the form 10b5-1 −2,191 $31.79 $69,652 672,007 D
2026-01-02 Sale : show line 3 in the form 10b5-1 −100 $32.39 $3,239 671,907 D
Open-market sales · 15,000 sh · avg $30.68 · $460,134
Loading xslF345X05/wk-form4_1767753388.xml…